Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology*; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology*; D004025:Dicyclomine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D005625:Frontal Lobe / Q000187:drug effects* / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D010276:Parasympatholytics / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology*; D010890:Pirenzepine; D051381:Rats; D011919:Rats, Inbred Strains; D011976:Receptors, Muscarinic / Q000187:drug effects*
D001570:Benzodiazepinones; D003509:Cyclohexanecarboxylic Acids; D010276:Parasympatholytics; D010627:Phenethylamines; D011976:Receptors, Muscarinic; D010890:Pirenzepine; D004025:Dicyclomine; C028187:secoverine; D000109:Acetylcholine; D004298:Dopamine